Forodesine Hydrochloride from Japan
Forodesine HCl is a purine nucleoside phosphorylase inhibitor with transition state analog structure for T-cell malignancies. The aromatic heterocyclic hydrochloride salt qualifies as a drug under HTS 2934.99.30.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Specify hydrochloride salt form stability and counterion exchange prevention
• Provide orphan drug and fast track designation documentation
• Document high potency API handling requirements (glove box filling)